VP 16-213 and cytosine-arabinoside combination chemotherapy for refractory acute lymphoblastic leukemia in adults
- 1 December 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (12) , 1471-1475
- https://doi.org/10.1016/0277-5379(84)90138-x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- AMSACRINE IN REFRACTORY ADULT ACUTE-LEUKEMIA - A PILOT-STUDY OF THE SOUTHEASTERN-CANCER-STUDY-GROUP1983
- Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patientsEuropean Journal of Cancer and Clinical Oncology, 1982
- VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemiaCancer, 1980
- Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemiaCancer, 1980
- Rapid remission induction in adult acute non-lymphoblastic leukaemiaPublished by Elsevier ,1978
- Combination chemotherapy for acute lymphoblastic leukaemia in adults.BMJ, 1978
- Combination chemotherapy for haematological relapse in adult acute lymphoblastic leukaemia (ALL)American Journal of Hematology, 1978
- Letter: Epipodophyllotoxin VP 16213 in acute non-lymphoblastic leukaemia.BMJ, 1975
- Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213Published by Elsevier ,1975